Association of pretreatment serum interferon inducible protein 10 levels with sustained virological response to peginterferon plus ribavirin therapy in genotype 1 infected patients with chronic hepatitis C

Association of pretreatment serum interferon inducible protein 10 levels with sustained virological response to peginterferon plus ribavirin therapy in genotype 1 infected patients with chronic hepatitis C

Item

http://www.wikidata.org/entity/Q27478305

Q27478305

about

Lack of response to exogenous interferon-α in the liver of chimpanzees chronically infected with hepatitis C virus Role of chemokines and their receptors in viral persistence and liver damage during chronic hepatitis C virus infection Predictors of sustained virological response to a 48-week course of pegylated interferon alfa-2a and ribavirin in patients infected with hepatitis C virus genotype 4 Therapeutic silencing of microRNA-122 in primates with chronic hepatitis C virus infection Vasculitic syndromes in hepatitis C virus: A review.Hepatic gene expression during treatment with peginterferon and ribavirin: Identifying molecular pathways for treatment response.Inducible protein-10 as a predictive marker of antiviral hepatitis C treatment: A systematic review.Low- and standard-dose peginterferon alfa-2a for chronic hepatitis C, genotype 2 or 3: efficacy, tolerability, viral kinetics and cytokine response.Changes in inflammatory biomarkers in HCV-infected patients undergoing direct acting antiviral-containing regimens with or without interferon The role of chemokines in the recruitment of lymphocytes to the liver.Gene expression profiling of dengue infected human primary cells identifies secreted mediators in vivo.Ribavirin improves early responses to peginterferon through improved interferon signaling The CXCR3(+)CD56Bright phenotype characterizes a distinct NK cell subset with anti-fibrotic potential that shows dys-regulated activity in hepatitis C Chemokine antagonism in chronic hepatitis C virus infection Impact of soluble CD26 on treatment outcome and hepatitis C virus-specific T cells in chronic hepatitis C virus genotype 1 infection Quantitation of pretreatment serum interferon-γ-inducible protein-10 improves the predictive value of an IL28B gene polymorphism for hepatitis C treatment response Interferon γ-induced protein 10 kinetics in treatment-naive versus treatment-experienced patients receiving interferon-free therapy for hepatitis C virus infection: implications for the innate immune response.Relevance of baseline viral genetic heterogeneity and host factors for treatment outcome prediction in hepatitis C virus 1b-infected patients Plasma interferon-gamma-inducible protein-10 levels are associated with early, but not sustained virological response during treatment of acute or early chronic HCV infection Danoprevir monotherapy decreases inflammatory markers in patients with chronic hepatitis C virus infection.Clinical implications of chemokines in acute and chronic hepatitis C virus infection.Serum IP-10 Levels Correlate with the Severity of Liver Histopathology in Patients Infected with Genotype-1 HCV.The Impact of IL28B Genotype and Liver Fibrosis on the Hepatic Expression of IP10, IFI27, ISG15, and MX1 and Their Association with Treatment Outcomes in Patients with Chronic Hepatitis C.Dynamic Changes of Post-Translationally Modified Forms of CXCL10 and Soluble DPP4 in HCV Subjects Receiving Interferon-Free Therapy.Association between CXCL10 and DPP4 Gene Polymorphisms and a Complementary Role for Unfavorable IL28B Genotype in Prediction of Treatment Response in Thai Patients with Chronic Hepatitis C Virus Infection.Predictive factors associated with hepatitis C antiviral therapy response.Chemokine CXCL10 at week 4 of treatment predicts sustained virological response in patients with chronic hepatitis C.Alanine aminotransferase, HCV RNA levels and pro-inflammatory and pro-fibrogenic cytokines/chemokines during acute hepatitis C virus infection Effector CD8 T cell trafficking within the liver Association of IL28B Genotypes and Baseline Serum Interferon-γ-Inducible- Protein-10 Levels with Treatment Response in Hepatitis C Virus Patients in China.The role of chemokines as inflammatory mediators in chronic hepatitis C virus infection.Intrahepatic levels of CXCR3-associated chemokines correlate with liver inflammation and fibrosis in chronic hepatitis C.Retreatment of chronic hepatitis C in previous non-responders and relapsers.Dynamic interplay between CXCL levels in chronic hepatitis C patients treated by interferon.B-Cell Activating Factor Belonging to the Tumor Necrosis Factor Family and Interferon-γ-Inducible Protein-10 in Autoimmune Hepatitis.Anti-inflammatory cytokines, pro-fibrogenic chemokines and persistence of acute HCV infection Sustained virologic response to peginterferon alpha-2a and ribavirin in 335 patients with chronic hepatitis C: a tertiary care center experience.Cellular and molecular interactions in coinfection with hepatitis C virus and human immunodeficiency virus.Management of nonresponsive hepatitis C.Mixing the right hepatitis C inhibitor cocktail.

P2860

Q27486088-61EED83A-F9F3-431B-962F-4791077FD444 Q27490393-8FAD6295-E624-4F61-91EA-CEC1F34ED7D5 Q27490866-C6247B9C-B808-4A53-8CDA-C84D92AFE5FF Q29615959-72BF7088-F73B-42F0-A981-443761270104 Q30238653-EA4CB301-2DFA-41E9-95B6-CC57E87AAFE7 Q33597579-2DF9083B-0B82-4115-8513-7106045869AB Q33706737-8B41E909-8F81-49A5-8DCC-CAE45F809161 Q33816657-AF2A31D2-6B3A-4970-9621-1C270AC6D667 Q33877898-261FEC0F-F989-453C-B834-C77EA420E9B0 Q33906565-36BA2868-3C5F-4B62-8F52-5A62578BD510 Q33945948-8BB53F9B-D930-434A-879F-99D5DC393BB2 Q33987120-198A1F34-9B21-48E4-9782-2EB5B14F4867 Q34335634-AB82C9E7-204D-48F0-B2EC-2FF1D713F793 Q34429056-D3EF02F5-7823-4E17-A032-0648E3074298 Q34599847-F63F1ADD-5E8F-484B-8169-5B93FA5B2C96 Q34867045-DB16B256-7010-47AC-A48E-D03E08884FE9 Q34974790-4C4A21A3-F700-4AC1-9392-885B95D2E65D Q34981566-7D24F2D4-6286-4E58-B06B-C6889A3E7B2C Q35053399-B04322AD-EF8A-4562-9536-689B0DAFF241 Q35065912-9A5455A2-CB3F-4923-BFF6-0253C2BFE41C Q35561908-23958936-2025-489C-A87F-CFC285B96042 Q35619177-6D9BB469-D142-4384-99BD-4C4785D8E71D Q35675852-636FF94B-C25D-4658-BB50-953C85D79685 Q35693436-2A9A18FD-FEDE-4FDD-86CA-1F00BA9A4404 Q35764450-FC7EE9BC-A9DA-4A7E-8D0F-68C1CDF7B6B9 Q35790397-000BB674-2052-449F-AC03-F0D84D6D7968 Q36172970-D82E123E-92C9-4D7E-AB51-CCC331E529B4 Q36611680-9AF926B8-EFF8-4013-B923-17B8DB05AD92 Q36625986-228127E7-9C64-4CE9-8BC6-4B3B28CC822A Q36848968-1047F415-8230-441B-A0AC-3254F1CC1779 Q36944050-C70276B5-37E4-4B90-A1EB-BD26A8BA0F32 Q36964114-1237AE2E-C289-44C3-9D98-F19E6EE2E9F3 Q36968144-6EBE6E40-E74B-43A1-BD62-505C6B52989F Q37000796-5308D71A-F38D-4C46-A347-99D20FC42468 Q37205477-DEDB63E1-50DD-48BE-8F6C-506F793EB262 Q37222199-32B9C24C-DED7-43A8-8FAC-EAD2A119F15C Q37243555-1BCF1E62-F01E-4D4E-B8D5-82B2DB84F513 Q37301305-E2DC6121-C0A1-49CA-8816-E26B4788D840 Q37727164-2E2AD6E0-A594-4BBE-95C4-0754941473E3 Q37812189-D7541628-8F40-4896-8F76-96137A89B7D7

P2860

Association of pretreatment serum interferon inducible protein 10 levels with sustained virological response to peginterferon plus ribavirin therapy in genotype 1 infected patients with chronic hepatitis C

Item

http://www.wikidata.org/entity/Q27478305

description

2006 nî lūn-bûn

@nan

2006 թուականի Մարտին հրատարակուած գիտական յօդուած

@hyw

2006 թվականի մարտին հրատարակված գիտական հոդված

@hy

2006年の論文

@ja

2006年論文

@yue

2006年論文

@zh-hant

2006年論文

@zh-hk

2006年論文

@zh-mo

2006年論文

@zh-tw

2006年论文

@wuu